Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hickman

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
The American Journal of Tropical Medicine and Hygiene|February 8, 2013
Drug discovery algorithm for cutaneous leishmaniasisMax Grogl, Mark Hickman, William Ellis, et al.
The American Journal of Tropical Medicine and Hygiene|October 28, 2015
Antileishmanial Activity of Compounds Derived from the Medicines for Malaria Venture Open Access Box Against Intracellular Leishmania major AmastigotesMozna Khraiwesh, Susan Leed, Norma Roncal, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2023
Efficacy of delafloxacin against the biothreat pathogen Bacillus anthracisSandra McCurdy, Stephanie A Halasohoris, Ashley L Babyak, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 30, 2013
Nanoparticle formulations of decoquinate increase antimalarial efficacy against liver stage Plasmodium infections in miceHongxing Wang, Qigui Li, Sean Reyes, et al.
Malaria Research and Treatment|May 12, 2017
Long-Term Prophylaxis and Pharmacokinetic Evaluation of Intramuscular Nano- and Microparticle Decoquinate in Mice Infected with <i>P. berghei</i> SporozoitesQigui Li, Lisa Xie, Diana Caridha, et al.
The American Journal of Tropical Medicine and Hygiene|March 27, 2013
An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolinesPeng Zhang, Xiugong Gao, Hiroshi Ishida, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2017
Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered <i>In Vivo</i> Screening Paradigm for Development of Drugs To Treat Cutaneous LeishmaniasisDiana Caridha, Sandi Parriot, Thomas H Hudson, et al.
ACS Chemical Biology|December 17, 2013
Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activityElizabeth R Sharlow, Stephanie Leimgruber, Samantha Murray, et al.
Malaria Journal|December 8, 2016
Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium bergheiErin E Milner, Jonathan Berman, Diana Caridha, et al.
Malaria Journal|February 16, 2019
Updating the modified Thompson test by using whole-body bioluminescence imaging to replace traditional efficacy testing in experimental models of murine malariaDiana Caridha, Mark Hickman, Lisa Xie, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The American Journal of Tropical Medicine and Hygiene|February 8, 2013
Drug discovery algorithm for cutaneous leishmaniasisMax Grogl, Mark Hickman, William Ellis, et al.
The American Journal of Tropical Medicine and Hygiene|October 28, 2015
Antileishmanial Activity of Compounds Derived from the Medicines for Malaria Venture Open Access Box Against Intracellular Leishmania major AmastigotesMozna Khraiwesh, Susan Leed, Norma Roncal, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2023
Efficacy of delafloxacin against the biothreat pathogen Bacillus anthracisSandra McCurdy, Stephanie A Halasohoris, Ashley L Babyak, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 30, 2013
Nanoparticle formulations of decoquinate increase antimalarial efficacy against liver stage Plasmodium infections in miceHongxing Wang, Qigui Li, Sean Reyes, et al.
Malaria Research and Treatment|May 12, 2017
Long-Term Prophylaxis and Pharmacokinetic Evaluation of Intramuscular Nano- and Microparticle Decoquinate in Mice Infected with <i>P. berghei</i> SporozoitesQigui Li, Lisa Xie, Diana Caridha, et al.
The American Journal of Tropical Medicine and Hygiene|March 27, 2013
An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolinesPeng Zhang, Xiugong Gao, Hiroshi Ishida, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2017
Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered <i>In Vivo</i> Screening Paradigm for Development of Drugs To Treat Cutaneous LeishmaniasisDiana Caridha, Sandi Parriot, Thomas H Hudson, et al.
ACS Chemical Biology|December 17, 2013
Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activityElizabeth R Sharlow, Stephanie Leimgruber, Samantha Murray, et al.
Malaria Journal|December 8, 2016
Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium bergheiErin E Milner, Jonathan Berman, Diana Caridha, et al.
Malaria Journal|February 16, 2019
Updating the modified Thompson test by using whole-body bioluminescence imaging to replace traditional efficacy testing in experimental models of murine malariaDiana Caridha, Mark Hickman, Lisa Xie, et al.
Pageof 3